Sweden· SE-20210129000025
CEVENFACTA 2 mg Pulver och vätska till injektionsvätska, lösning
A medicinal product containing eptacog beta (activated), registered in Sweden by Laboratoire français du Fractionnement et des Biotechnologies.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Eptacog Beta (Activated)
- Manufacturer
- Laboratoire français du Fractionnement et des Biotechnologies
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20210129000025
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Eptacog beta (activated) in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomCevenfacta 2mg (90,000units) powder and solvent for solution for injection vialsLFB Biopharmaceuticals Ltd
- BelgiumCevenfacta 2 mgLaboratoire français du Fractionnement et des Biotechnologies
- SpainNOVOSEVEN 2 mg (100 KUI) POLVO Y DISOLVENTE PARA SOLUCION INYECTABLENovo Nordisk A/S
- NorwayNovoSevenNovo Nordisk A/S
- IrelandCEVENFACTA 1 mg (45 KIU) powder and solvent for solution for injectionLaboratoire francais du Fractionnement et des Biotechnolgies
- CzechiaCEVENFACTALaboratoire Français du Fractionnement et des Biotechnologies, Puteaux
- FinlandNovosevenNovo Nordisk A/S
- SwitzerlandNovoSeven 1 mg, Pulver und Lösungsmittel zur Herstellung einer InjektionslösungNovo Nordisk Pharma AG
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Cevenfacta, Novoseven
- Liechtenstein · Cevenfacta
- Norway · Cevenfacta, Novoseven
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ff456902-1f2e-44dc-8a5a-93276de225ab GET /v1/drugs/ff456902-1f2e-44dc-8a5a-93276de225ab?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"EMA",
"EPAR"
],
"se_npl_id": "20210129000025",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20210129000025",
"product_doc_link": "https://www.ema.europa.eu/en/medicines/human/EPAR/cevenfacta"
}See everything about eptacog beta (activated).
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.